Liberty Biopharma Inc (CVE:LTY – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Stock Up ∞
The business’s fifty day moving average is C$2.00 and its two-hundred day moving average is C$2.00. The stock has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- What Does Downgrade Mean in Investing?
- How to Invest in Small Cap Stocks
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- These Are the Dividend Stocks Insiders Bought in January
- Investing In Automotive Stocks
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
